Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Hadas

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
The European Respiratory Journal|February 1, 1996
Pulmonary function abnormalities in type I Gaucher diseaseE Kerem, D Elstein, A Abrahamov, et al.
The American Journal of Medicine|July 1, 1994
Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatmentA Zimran, D Elstein, R Kannai, et al.
Brain Research Bulletin|June 7, 2008
Antidepressive-like effects of rapamycin in animal models: Implications for mTOR inhibition as a new target for treatment of affective disordersC Cleary, J A S Linde, K M Hiscock, et al.
Lancet (London, England)|October 14, 1995
Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotypeA Abrahamov, D Elstein, V Gross-Tsur, et al.
Lancet (London, England)|June 10, 1995
Replacement therapy with imiglucerase for type 1 Gaucher's diseaseA Zimran, D Elstein, E Levy-Lahad, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
The European Respiratory Journal|February 1, 1996
Pulmonary function abnormalities in type I Gaucher diseaseE Kerem, D Elstein, A Abrahamov, et al.
The American Journal of Medicine|July 1, 1994
Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatmentA Zimran, D Elstein, R Kannai, et al.
Brain Research Bulletin|June 7, 2008
Antidepressive-like effects of rapamycin in animal models: Implications for mTOR inhibition as a new target for treatment of affective disordersC Cleary, J A S Linde, K M Hiscock, et al.
Lancet (London, England)|October 14, 1995
Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotypeA Abrahamov, D Elstein, V Gross-Tsur, et al.
Lancet (London, England)|June 10, 1995
Replacement therapy with imiglucerase for type 1 Gaucher's diseaseA Zimran, D Elstein, E Levy-Lahad, et al.
Pageof 5